Treatment of rats with phenobarbital, which stimulates the activity of the drug-metabolizing enzymes in the liver, potentiates hepatic necrosis elicited by bromobenzene and a number of other chemically inert halogenated aromatic hydrocarbons. Radioautographic studies indicate that ['4Clbromobenzene is covalently bound at the sites of necrosis. From these results, it is inferred that the hepatotoxic effects of the halogenated aromatic hydrocarbons are mediated by chemically active metabolites formed in hepatocytes. In accord with this view, a number of aromatic halogenated hydrocarbons are converted by microsomes in vitro to active intermediates which form covalent complexes with glutathione (GSH).
Although drugs are generally converted in the body to derivatives that are less toxic than the parent compounds, many therapeutic agents occasionally produce tissue damage, such as hepatic and renal necrosis, blood dyscrasias, and other lesions. Some years ago Brodie suggested (1) that chemically inert therapeutic drugs may cause tissue lesions by the formation of a covalent linkage between a chemically active metabolite and various macromoles. A similar mechanism has been invoked to account for the carcinogenic activity of chemically inert substances, such as dialkylnitrosamines, azo dyes, Nacetyl-aminofluorene, and polycyclic hydrocarbons (2) . To test the view that other tissue lesions caused by chemically stable organic compounds might be mediated through active metabolites, we have investigated the toxic mechanisms of bromobenzene and other aromatic hydrocarbons that are known to cause liver necrosis in various animal species (3, 4) .
METHODS

Histologic studies in vivo
MIale Sprague-Dawley rats (NIH, about 180 g) were injected for three successive days with saline or with phenobarbital (80 mg/kg, i.p.). On the fourth day, three groups of four animals each were injected with various doses of organic compounds (i.p. in 0.5-2 ml of sesame oil). 24 hr later, the livers were removed and slices 1-2 mm thick were fixed in buffered formalin, dehydrated in graded strengths of ethanol, cleared in xylol, and embedded in paraffin. Sections (6 /Am thick) were stained with periodic acid-Schiff reagent (PAS) and hematoxylin (5 Harris's hematoxylin (6) .
In vitro formation of glutathione (GSH) conjugates
Highly electrophilic metabolites (alkylating agents) formed from the aromatic hydrocarbons were trapped by allowing them to form a covalent bond with GSH, a potent nucleophil. Various compounds were incubated with GSH plus dialyzed hepatic soluble fraction containing GSH transferase activity, liver microsomes from normal or phenobarbital-treated rats, and a NADPH-generating system for 1 hr at 370C (7) . The final concentrations in the incubation mixture (final volume 2.5 ml) were as follows: 0.5-30 mM hydrocarbon, 3 mM [35S]GSH (1 MCi/tube), 0.124 mM NADH, 2 mM nicotinamide, 0.2 mM NADP, 2 mM glucose-6-phosphate, 1 unit/ml glucose-6-phosphate dehydrogenase, 4 to 10 mg l)rotein/ml liver microsomes, and 0.2 ml/ml of the soluble fraction. After the incubation, the hydrocarbon-GSH conjugates were separated by adsorption onto charcoal followed by paper chromatography (7) .
RESULTS
Histologic studies
A number of halogenated compounds, many of which are listed in Table 1 , produced necrosis of centrolobular parenchymal cells in liver. In a typical experiment, the histology of a normal liver (Fig. 1A) was compared with that of a liver from a rat injected with bromobenzene (0.2 ml) 24 Prior treatment of animals with phenobarbital markedly increased the centrolobular hepatotoxicity of a number of aromatic hydrocarbons. For example, a low dose of bromobenzene (0.03 ml), which caused little toxicity in untreated animals ( Fig. 1C) , produced extensive centrolobular necrosis inl l)henobarbital-treated rats (Fig. 1D ). Phenobarbital administration also markedly increased the toxicity of chlorobenzeue, iodobenzene, chlorinated naphthalenes, and 1,2-and 1,3-dichlorobenzenes (Table 1) . However, benzene and 1,4-dichlorobenzene did not produce liver lesions either in normal or in l)henobarbital-treated rats. Moreover, the conjugate did not form when the microsomes, the NADPH-generating system, or 02 were omitted from the incubation system. When the complete system was incubated in a CO-02 (9: 1) atmosphere, the formation of the conjugate was markedly reduced, which indicates that an NADPHdependent CO-sensitive enzyme was also required. Furthermore, the alkylation of GSH was considerably decreased when liver microsomes and soluble fraction from rats not previously treated with phenobarbital were used ( (Fig. 2) . The important role of microsomal enzymes in the "activation" of aromatic hydrocarbons is emphasized by the following facts: the severity of necrosis is increased in animals that were first pretreated with phenobarbital, a drug which causes a proliferation of the endoplasmic reticulum in centrolobular hepatocytes (8) and induces the synthesis of the enzymes that metabolize foreign compounds (9) ; the severity of necrosis is decreased (unpublished data) by ,3-diethylaminoethyl diphenylpropylacetate (SKF 525A), which decreases the activity of these enzymes (10) ; and the in vitro formation of GSH conjugates of halogenated hydrocarbons requires liver microsomes (7) , and is enhanced in microsomes from phenobarbitaltreated rats.
Previous studies on the mechanism of mercapturic acid and dihydrodiol formation both in vivo and in liver preparations have led to the view that a number of aromatic hydrocarbons are intially converted to epoxides by liver microsomes (11, 12) ; indeed, direct proof for the formation of napththalene epoxide was recently obtained by Jerina et al. (13, 14) . According to the current view, the epoxides are then converted nonenzymatically to phenols or enzymatically to their GSH conjugates and dihydrodiol derivatives (15, 16) . Subsequently, the GSH conjugates are transformed and excreted in urine as premercapturic acids while the dihydrodiol derivatives are converted to catechols. The (17) , since prior pretreatment of rats with phenobarbital enhances the toxic effects of CCl4 (18, 19) . Similarly, dialkylnitrosamines are thought to exert their hepatotoxie effects through the formation of diazo alkylating derivatives (20) .
Some compounds produce necrosis in the periportal rather than ia the centrolobular regions of the liver. Reid et al. (21) have confirmed the findings of Eger (22) that allyl alcohol and its precursor, allyl formate (23), leroduce l)erilportal rather than centrolobular necrosis and have shown that the hepatotoxicity of these compounds is not affected by previous treatment of the rats with phenobarbital. It should be pointed out that these hepatotoxic agents are activated by enzymes other than those in endoplasmic reticulum. In fact, Rees and Tarlow (24) have shown that allyl formate is converted to the highly reactive aldehyde, acroleia, by alcohol dehydrogeniase and that this enzyme is localized in the periportal zone.
In conclusion, the liver (and perhaps other organs) can convert stable organic compounds to potent alkylating agents, which form covalent bonds with tissue macromolecules. The possibility must be considered that the therapeutic agents that occasionally cause damage to liver, kidney, bone marrow, and other tissues may also form small amounts of alkylating agents in these organs. Similarly, allergic responses to drugs may be mediated through antigens formed by the reaction of body lroteins with trace amounts of chemically active drug metabolites (25) . According to this view, the drug-metabolizing
